PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 668 of 767

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

VERAXA adds 60% more lab space in Heidelberg for cancer drug work

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA gives CalciMedica no comments on Auxora safety review

Stock TitanOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Ollin hauls in $330M to enlist Vabysmo challenger in phase 3 eye disease gauntlet

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026

Business WireOriginal source
🌍discoverynews.google.comTier 2 · Trade media

ŌURA and Lilly join forces to harmonise drug-wearable obesity care

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries rises Wednesday, outperforms competitors

MarketWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How UPS is Adressing pharmaceutical Procurement Challenges

Procurement MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma says Phase 3 depression trial is 86% enrolled

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA cracks down on counterfeit cosmetics, illegal drug sales

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The new drug compound that could treat measles outbreaks – and other viruses

Drug Discovery NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CORXEL’s oral obesity drug clears Phase II test

The PharmaletterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sangamo files for bankruptcy as Lilly and Astellas target assets

The PharmaletterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Former Vertex, GSK exec launches science-first pet nutrition company

The Business JournalsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Early Biomarkers as Predictors of Nephrology Trial Trajectory

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0670 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “JIE TOU QI SHI”

fda.gov.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Advisory No.2026-0669 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Beauluck Tablet”

fda.gov.phOriginal source
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

South Africa needs the mother of all in(ter)ventions

Stellenbosch UniversityOriginal source
🌍discoverynews.google.comTier 2 · Trade media

The Things to Think About Before Taking Your Biotech Company Public

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

USFDA Rejects Achieve's Smoking-Cessation Drug Cytisinicline Over Manufacturing Issues

Medical DialoguesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

SahmOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection

SahmOriginal source
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

New Dean of Students on building belonging at SU

Stellenbosch UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Omega-3 API Market to Reach USD 2.3 Billion by 2036 as Prescription Cardiovascular Therapies Drive Demand for High-Purity EPA APIs, FMI

24-7 Press Release NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What is the FDA Role in a New Initiative to Speed Up Drug Trials from the Department of Health

KRZK 106.3Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Coiled Therapeutics appoints biotech veteran Craig Tooman to board

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Opens RASolute 305 Trial of Zoldonrasib in RAS G12D Pancreatic Cancer

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

When Your Sponsor Gets Acquired Mid-Trial, Your Site Pays the Operational Price

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FIRST AID: Socialists target biotech sweetener

EuractivOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

McKesson Selects Moore, Oklahoma for $179 Million State-of-the-Art Pharmaceutical Distribution Center

EIN PresswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[Bio USA] Korean biotech has innovation. Now it needs capital

The Korea HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson's Therapy

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma.AI Summer Update Preview: Drive the future of pharmaceutical intelligence

Insilico MedicineOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Reuters Health News Summary

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is West Pharmaceutical Services (WST) Pricey As GLP 1 Demand Lifts Expectations?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (TEVA) Stock After 94% One-Year Surge Is The Price Justified

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals seeks $10m capital injection

AFROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA backs AFT’s injectable iron into Phase 3 study as company targets global scale

BiotechDispatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[Global Pharma Leadership Voices] The future of pharmaceutical innovation begins where patients still wait

koreabiomed.comOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Novo Nordisk filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Sanofi filed Form 6-K

SEC EDGAROriginal source
🇺🇰Regulatorynice.org.ukTier 1 · Regulatory source

New treatment option recommended for recurrent or metastatic cervical cancer

NICEOriginal source
🇿🇦Researchnews.uct.ac.zaTier 2 · Direct publisher

Prenatal air pollution raises babies’ breathing risks

University of Cape TownOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Chickens-Gallus Gallus; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Felines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Canines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Porcines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Equines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Caprines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Ovines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Bovines; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: General Recommendations; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

This request for information seeks input from the public on whether any additions or modifications a...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction

On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Amanda Ward, N.D.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Irina Gross, D.P.M.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Fiscal Year (FY) 2026 Notice of Supplemental Funding Opportunity

This notice is to inform the public that the Substance Abuse and Mental Health Services Administrati...

Federal RegisterOriginal source